News

Primary results from S1613 in colorectal cancer are now in JCO

When CRC is HER2+, dual HER2 inhibitor may beat standard EGFR inhibitors

Improving the TM proposal process with a consolidated, streamlined form

For every trial we open, SWOG takes steps to make enrollment as rapid and representative as possible

The PROSPECT-Lung trial opens just as Pragmatica-Lung is closing